Fuso Chemical Co.,Ltd. Beat Revenue Forecasts By 8.0%: Here's What Analysts Are Forecasting Next
There's been a notable change in appetite for Fuso Chemical Co.,Ltd. (TSE:4368) shares in the week since its quarterly report, with the stock down 14% to JP¥3,355. Results overall were respectable, with statutory earnings of JP¥135 per share roughly in line with what the analysts had forecast. Revenues of JP¥23b came in 8.0% ahead of analyst predictions. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Fuso ChemicalLtd after the latest results.
Taking into account the latest results, the most recent consensus for Fuso ChemicalLtd from four analysts is for revenues of JP¥90.9b in 2027. If met, it would imply a meaningful 12% increase on its revenue over the past 12 months. Per-share earnings are expected to expand 14% to JP¥193. Before this earnings report, the analysts had been forecasting revenues of JP¥89.2b and earnings per share (EPS) of JP¥193 in 2027. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.
Check out our latest analysis for Fuso ChemicalLtd
The consensus price target rose 8.3% to JP¥5,633despite there being no meaningful change to earnings estimates. It could be that the analystsare reflecting the predictability of Fuso ChemicalLtd's earnings by assigning a price premium. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. There are some variant perceptions on Fuso ChemicalLtd, with the most bullish analyst valuing it at JP¥5,900 and the most bearish at JP¥5,200 per share. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. The analysts are definitely expecting Fuso ChemicalLtd's growth to accelerate, with the forecast 17% annualised growth to the end of 2027 ranking favourably alongside historical growth of 8.2% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 5.0% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Fuso ChemicalLtd to grow faster than the wider industry.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analysts believes the intrinsic value of the business is likely to improve over time.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Fuso ChemicalLtd going out to 2029, and you can see them free on our platform here.
That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Fuso ChemicalLtd , and understanding it should be part of your investment process.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.